HC Wainwright & Co. analyst Raghuram Selvaraju maintains Equillium (NASDAQ:EQ) with a Buy and raises the price target from $15 to $20.
Amneal Pharmaceuticals Stock Gaines: It Raised FY23 Outlook On Prescription Trends, Pricing Levels Strength
Amneal Pharmaceuticals Inc (NYSE: AMRX) reports Q2 revenue of $599 million, an increase of 7% Y/Y, beating the consensus of $5